Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02159's Current Ratio is ranked better than 63.58% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs HKSE:02159: 1.89
Mediwelcome Healthcare Management & Technology (HKSE:02159) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Mediwelcome Healthcare Management & Technology Current Ratio Related Terms
Mediwelcome Healthcare Management & Technology Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology Current Ratio Chart
Mediwelcome Healthcare Management & Technology Annual Data
HKSE:02159 vs VEEV, BTSG, TEM: Current Ratio Comparison
For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediwelcome Healthcare Management & Technology Current Ratio vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a Current Ratio of 1.89 as of Dec. 2025. This is 12% below median its historical median of 2.15. Over the past decade, Mediwelcome Healthcare Management & Technology's Current Ratio has ranged from 1.37 to 4.81. According to the industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #248 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 36.4%.
Is Mediwelcome Healthcare Management & Technology's Current Ratio too high?
Mediwelcome Healthcare Management & Technology's current Current Ratio of 1.89 is 12% below median its 10-year median of 2.15. Over the past 10 years, this metric has ranged from a low of 1.37 to a high of 4.81. The Healthcare Providers & Services industry median Current Ratio is 1.47. Mediwelcome Healthcare Management & Technology's value of 1.89 is 28.6% above this industry median. Based on the distribution chart, Mediwelcome Healthcare Management & Technology ranks #248 out of 681 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's Current Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #248 out of 681 companies for Current Ratio. This puts Mediwelcome Healthcare Management & Technology in the upper half of its industry. The industry median Current Ratio is 1.47. Mediwelcome Healthcare Management & Technology's value of 1.89 is 28.6% above this benchmark. Historically, Mediwelcome Healthcare Management & Technology's own Current Ratio has ranged from 1.37 to 4.81 over the past decade. While the company's 10-year median is 2.15 vs. the industry median of 1.47, Mediwelcome Healthcare Management & Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediwelcome Healthcare Management & Technology's current Current Ratio of 1.89 is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediwelcome Healthcare Management & Technology's current Current Ratio is 1.89, which is 12% below median its own 10-year median of 2.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.69, compared to a current price of HK$1.55 — trading 124.6% above its estimated fair value. The current Current Ratio is 1.89, which is 12% below median its 10-year median of 2.15 and 28.6% above the Healthcare Providers & Services industry median of 1.47. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current Current Ratio is 1.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued.
The current stock price of HK$1.55 is trading 124.6% above its estimated GF Value™ of HK$0.69.
GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.
Key valuation signals for HKSE:02159:
Current Ratio: 1.89 (12% below median its 10-year median of 2.15)
GF Value™: HK$0.69 vs. price of HK$1.55 (124.6% above fair value)
Industry Position: 28.6% above the Healthcare Providers & Services median (#248 of 681)
No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mediwelcome Healthcare Management & Technology Business Description
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
56GF Score
Get the complete analysis for HKSE:02159
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02159 has been successfully added to your 
